Original Article
Clinical significance of serum tumor markers for advanced gastric cancer with the first-line chemotherapy
Translational Cancer Research
2019;
8
(8)
:2680-2690
.
(31 December 2019)
Down-regulated hsa_circ_0067934 facilitated the progression of gastric cancer by sponging hsa-mir-4705 to downgrade the expression of BMPR1B
Translational Cancer Research
2019;
8
(8)
:2691-2703
.
(31 December 2019)
Reduced RANBP9 expression is associated with poor prognosis in colorectal cancer patients
Translational Cancer Research
2019;
8
(8)
:2704-2712
.
(31 December 2019)
MicroRNA-200c affects bladder cancer angiogenesis by regulating the Akt2/mTOR/HIF-1 axis
Translational Cancer Research
2019;
8
(8)
:2713-2724
.
(31 December 2019)
ADAMTS-1 inhibits angiogenesis via the PI3K/Akt-eNOS-VEGF pathway in lung cancer cells
Translational Cancer Research
2019;
8
(8)
:2725-2735
.
(31 December 2019)
Analysis of volatile organic compounds released from SW480 colorectal cancer cells and the blood of tumor-bearing mice
Translational Cancer Research
2019;
8
(8)
:2736-2751
.
(31 December 2019)
Predictive value of preoperative weight loss on survival of elderly patients undergoing surgery for esophageal squamous cell carcinoma
Translational Cancer Research
2019;
8
(8)
:2752-2758
.
(31 December 2019)
HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin
Translational Cancer Research
2019;
8
(8)
:2759-2768
.
(31 December 2019)
LncRNA CASC9 regulates cell proliferation, apoptosis and cell cycle via sponging miR-145-5p in colon cancer cells
Translational Cancer Research
2019;
8
(8)
:2769-2780
.
(31 December 2019)
The application of methylene blue coloration technique in axillary lymph node dissection of breast cancer
Translational Cancer Research
2019;
8
(8)
:2781-2790
.
(31 December 2019)
miR-203a-3p regulates the cellular processes of esophageal cancer cells via targeting CtBP2
Translational Cancer Research
2019;
8
(8)
:2791-2802
.
(31 December 2019)
Noninvasive circulating tumor cell and urine cellular XPC (rs2228001, A2815C) and XRCC1 (rs25487, G1196A) polymorphism detection as an effective screening panel for genitourinary system cancers
Translational Cancer Research
2019;
8
(8)
:2803-2812
.
(31 December 2019)
Association between Chlamydia pneumoniae infection and lung cancer: a meta-analysis
Translational Cancer Research
2019;
8
(8)
:2813-2819
.
(31 December 2019)
Selective lymph node dissection for clinical T1 stage non-small cell lung cancer
Translational Cancer Research
2019;
8
(8)
:2820-2828
.
(31 December 2019)
Identification of key protein-coding genes in lung adenocarcinomas based on bioinformatic analysis
Translational Cancer Research
2019;
8
(8)
:2829-2840
.
(31 December 2019)
Plasma enhance drug sensitivity to bortezomib by inhibition of cyp1a1 in myeloma cells
Translational Cancer Research
2019;
8
(8)
:2841-2847
.
(31 December 2019)
An improved method to build lung cancer PDX models by surgical resection samples and its association with B7-H3 expression
Translational Cancer Research
2019;
8
(8)
:2848-2857
.
(31 December 2019)
Effect of icotinib on advanced lung adenocarcinoma patients with sensitive EGFR mutation detected in ctDNA by ddPCR
Translational Cancer Research
2019;
8
(8)
:2858-2863
.
(31 December 2019)
Utilization of combined PD-L1 expression and neutrophil-to-lymphocyte ratio prior to surgery as a prognostic factor in non-small cell lung cancer with brain metastasis
Translational Cancer Research
2019;
8
(8)
:2864-2877
.
(31 December 2019)
Dosimetric comparison of dose accumulation between rigid registration and deformation registration in intensity-modulated radiation therapy for large volume non-small cell lung cancer
Translational Cancer Research
2019;
8
(8)
:2878-2885
.
(31 December 2019)
Study of the dose-volume parameters variation in tumor target volumes and organs at risk during nasopharyngeal carcinoma radiotherapy applying deformation registration
Translational Cancer Research
2019;
8
(8)
:2886-2892
.
(31 December 2019)
Study on the differences of opinions and choices of high-risk breast cancer populations in China before and after genetic testing
Translational Cancer Research
2019;
8
(8)
:2893-2905
.
(31 December 2019)
Girdin knockdown promotes apoptosis in colorectal cancer via miR-29c-3p/Girdin axis
Translational Cancer Research
2019;
8
(8)
:2906-2915
.
(31 December 2019)
Review Article
Disorders of neural crest derivates in oncoradiological practice
Translational Cancer Research
2019;
8
(8)
:2916-2923
.
(31 December 2019)
Invasive mucinous adenocarcinoma of the lung
Translational Cancer Research
2019;
8
(8)
:2924-2932
.
(31 December 2019)
Case Report
Primary lung cancer firstly presents as nephrotic syndrome: one case report and literature review
Translational Cancer Research
2019;
8
(8)
:2933-2935
.
(31 December 2019)
Skeletal muscle metastasis from squamous cell lung cancer was first found by ultrasound: a case report
Translational Cancer Research
2019;
8
(8)
:2936-2940
.
(31 December 2019)
Letter to the Editor
PD-1/PD-L1 inhibitors as a hope for smokers of non-small cell lung cancer patient
Translational Cancer Research
2019;
8
(8)
:2941-2943
.
(31 December 2019)
Editorial Commentary
The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
Translational Cancer Research
2019;
8
(8)
:E1-E6
.
(31 December 2019)
Role of artificial intelligence in integrated analysis of multi-omics and imaging data in cancer research
Translational Cancer Research
2019;
8
(8)
:E7-E10
.
(31 December 2019)
Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer
Translational Cancer Research
2019;
8
(8)
:E11-E14
.
(31 December 2019)
N-Myc a key gene promoting a worst prostate cancer progression
Translational Cancer Research
2019;
8
(8)
:E15-E17
.
(31 December 2019)
Carboplatin, nab-paclitaxel plus atezolizumab in IMpower 130 trial: new weapons beyond controversies
Translational Cancer Research
2019;
8
(8)
:E18-E23
.
(31 December 2019)
